MetaCap

Ligand Pharmaceuticals (LGND) News

NASDAQ: LGNDHealth CareBiotechnology: Pharmaceutical PreparationsUSD

286.85-0.09 (-0.03%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

LGND news summary

We found 8 recent headlines mentioning Ligand Pharmaceuticals (LGND): 0 in the past week and 5 in the past 30 days, most often from GlobeNewswire, Nasdaq, Seeking Alpha. For price context, LGND is down 0.03% at $286.85. The most recent story, "Ligand Reports Third Quarter 2026 Financial Results", was published by Nasdaq on Oct 29, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Ligand Pharmaceuticals headlines

Stocks mentioned alongside LGND

Compare LGND